Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells

ABSTRACT Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that are significant risk factors in the development of cancer, and HPV accounts for approximately 5% of all worldwide cancers. Recent studies using data from The Cancer Genome Atlas (TCGA) have demonstrated that elevated...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Molly L. Bristol, Claire D. James, Xu Wang, Christian T. Fontan, Iain M. Morgan
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2020
Materias:	HNSCC HPV cancer estrogen keratinocyte transcription Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/8b08ab478e534aa2821837bb1e4e1c1c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8b08ab478e534aa2821837bb1e4e1c1c
record_format	dspace
spelling	oai:doaj.org-article:8b08ab478e534aa2821837bb1e4e1c1c2021-11-15T15:29:16ZEstrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells10.1128/mSphere.00049-202379-5042https://doaj.org/article/8b08ab478e534aa2821837bb1e4e1c1c2020-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00049-20https://doaj.org/toc/2379-5042ABSTRACT Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that are significant risk factors in the development of cancer, and HPV accounts for approximately 5% of all worldwide cancers. Recent studies using data from The Cancer Genome Atlas (TCGA) have demonstrated that elevated levels of estrogen receptor alpha (ERα) are associated with improved survival in oropharyngeal cancers, and these elevated receptor levels were linked with human papillomavirus-positive cancers (HPV+cancers). There has been a dramatic increase in HPV-related head and neck squamous cell carcinomas (HPV+HNSCCs) over the last 2 decades, and therapeutic options for this ongoing health crisis are a priority; currently, there are no antiviral therapeutics available for combatting HPV+cancers. During our TGCA studies on head and neck cancer, we had also discovered the overexpression of ERα in HPV+cancers. Here, we demonstrate that 17β-estradiol (estrogen) attenuates the growth/cell viability of HPV+cancers in vitro, but not HPV-negative cancer cells. In addition, N/Tert-1 cells (foreskin keratinocytes immortalized with human telomerase reverse transcriptase [hTERT]) containing human papillomavirus 16 (HPV16) have elevated levels of ERα and growth sensitivity after estrogen treatment compared with parental N/Tert-1 cells. Finally, we demonstrate that there are potentially two mechanisms contributing to the attenuation of HPV+ cell growth following estrogen treatment. First, estrogen represses the viral transcriptional long control region (LCR) downregulating early gene expression, including E6/E7. Second, expression of E6 and E7 by themselves sensitizes cells to estrogen. Overall, our results support the recent proposal that estrogen could be exploited therapeutically for the treatment of HPV-positive oral cancers. IMPORTANCE Human papillomaviruses cause around 5% of all human cancers, yet there are no specific antiviral therapeutic approaches available for combatting these cancers. These cancers are currently treated with standard chemoradiation therapy (CRT). Specific antiviral reagents are desperately required, particularly for HPV+HNSCC whose incidence is increasing and for which there are no diagnostic tools available for combatting this disease. Using data from The Cancer Genome Atlas (TCGA), we and others determined that the estrogen receptor alpha (ERα) is overexpressed in HPV+HNSCC and that elevated levels are associated with an improved disease outcome. This has led to the proposal that estrogen treatment could be a novel therapeutic approach for combatting HPV+cancers. Here, we demonstrate that estrogen attenuates the growth of HPV+epithelial cells using multiple mechanisms, supporting the idea that estrogen has potential as a therapeutic agent for the treatment of HPV+HNSCC.Molly L. BristolClaire D. JamesXu WangChristian T. FontanIain M. MorganAmerican Society for MicrobiologyarticleHNSCCHPVcancerestrogenkeratinocytetranscriptionMicrobiologyQR1-502ENmSphere, Vol 5, Iss 2 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	HNSCC HPV cancer estrogen keratinocyte transcription Microbiology QR1-502
spellingShingle	HNSCC HPV cancer estrogen keratinocyte transcription Microbiology QR1-502 Molly L. Bristol Claire D. James Xu Wang Christian T. Fontan Iain M. Morgan Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
description	ABSTRACT Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that are significant risk factors in the development of cancer, and HPV accounts for approximately 5% of all worldwide cancers. Recent studies using data from The Cancer Genome Atlas (TCGA) have demonstrated that elevated levels of estrogen receptor alpha (ERα) are associated with improved survival in oropharyngeal cancers, and these elevated receptor levels were linked with human papillomavirus-positive cancers (HPV+cancers). There has been a dramatic increase in HPV-related head and neck squamous cell carcinomas (HPV+HNSCCs) over the last 2 decades, and therapeutic options for this ongoing health crisis are a priority; currently, there are no antiviral therapeutics available for combatting HPV+cancers. During our TGCA studies on head and neck cancer, we had also discovered the overexpression of ERα in HPV+cancers. Here, we demonstrate that 17β-estradiol (estrogen) attenuates the growth/cell viability of HPV+cancers in vitro, but not HPV-negative cancer cells. In addition, N/Tert-1 cells (foreskin keratinocytes immortalized with human telomerase reverse transcriptase [hTERT]) containing human papillomavirus 16 (HPV16) have elevated levels of ERα and growth sensitivity after estrogen treatment compared with parental N/Tert-1 cells. Finally, we demonstrate that there are potentially two mechanisms contributing to the attenuation of HPV+ cell growth following estrogen treatment. First, estrogen represses the viral transcriptional long control region (LCR) downregulating early gene expression, including E6/E7. Second, expression of E6 and E7 by themselves sensitizes cells to estrogen. Overall, our results support the recent proposal that estrogen could be exploited therapeutically for the treatment of HPV-positive oral cancers. IMPORTANCE Human papillomaviruses cause around 5% of all human cancers, yet there are no specific antiviral therapeutic approaches available for combatting these cancers. These cancers are currently treated with standard chemoradiation therapy (CRT). Specific antiviral reagents are desperately required, particularly for HPV+HNSCC whose incidence is increasing and for which there are no diagnostic tools available for combatting this disease. Using data from The Cancer Genome Atlas (TCGA), we and others determined that the estrogen receptor alpha (ERα) is overexpressed in HPV+HNSCC and that elevated levels are associated with an improved disease outcome. This has led to the proposal that estrogen treatment could be a novel therapeutic approach for combatting HPV+cancers. Here, we demonstrate that estrogen attenuates the growth of HPV+epithelial cells using multiple mechanisms, supporting the idea that estrogen has potential as a therapeutic agent for the treatment of HPV+HNSCC.
format	article
author	Molly L. Bristol Claire D. James Xu Wang Christian T. Fontan Iain M. Morgan
author_facet	Molly L. Bristol Claire D. James Xu Wang Christian T. Fontan Iain M. Morgan
author_sort	Molly L. Bristol
title	Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
title_short	Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
title_full	Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
title_fullStr	Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
title_full_unstemmed	Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
title_sort	estrogen attenuates the growth of human papillomavirus-positive epithelial cells
publisher	American Society for Microbiology
publishDate	2020
url	https://doaj.org/article/8b08ab478e534aa2821837bb1e4e1c1c
work_keys_str_mv	AT mollylbristol estrogenattenuatesthegrowthofhumanpapillomaviruspositiveepithelialcells AT clairedjames estrogenattenuatesthegrowthofhumanpapillomaviruspositiveepithelialcells AT xuwang estrogenattenuatesthegrowthofhumanpapillomaviruspositiveepithelialcells AT christiantfontan estrogenattenuatesthegrowthofhumanpapillomaviruspositiveepithelialcells AT iainmmorgan estrogenattenuatesthegrowthofhumanpapillomaviruspositiveepithelialcells
_version_	1718427896658264064

Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells

Ejemplares similares